NO970886D0 - Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotid konjugater med terpyridin-metallkomplekser - Google Patents

Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotid konjugater med terpyridin-metallkomplekser

Info

Publication number
NO970886D0
NO970886D0 NO970886A NO970886A NO970886D0 NO 970886 D0 NO970886 D0 NO 970886D0 NO 970886 A NO970886 A NO 970886A NO 970886 A NO970886 A NO 970886A NO 970886 D0 NO970886 D0 NO 970886D0
Authority
NO
Norway
Prior art keywords
terpyridine
metal complexes
pct
preparation
functional
Prior art date
Application number
NO970886A
Other languages
English (en)
Other versions
NO316866B1 (no
NO970886L (no
Inventor
Robert Haener
Jonathan Hall
Dieter Huesken
Uwe Pieles
Heinz Moser
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO970886D0 publication Critical patent/NO970886D0/no
Publication of NO970886L publication Critical patent/NO970886L/no
Publication of NO316866B1 publication Critical patent/NO316866B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO19970886A 1994-09-02 1997-02-27 Funksjonelle terpyridin-metallkomplekser, fremgangsmater for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser, forbindelse for anvendelse i en terapeutisk fremgangsmate, farmasoytisk preparat og anvendelse av en forbindelse t NO316866B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269394 1994-09-02
PCT/EP1995/003409 WO1996007668A1 (de) 1994-09-02 1995-08-30 Funktionelle terpyridin-metallkomplexe, verfahren zu deren herstellung und oligonukleotid-konjugate mit terpyridin-metallkomplexen

Publications (3)

Publication Number Publication Date
NO970886D0 true NO970886D0 (no) 1997-02-27
NO970886L NO970886L (no) 1997-04-25
NO316866B1 NO316866B1 (no) 2004-06-07

Family

ID=4239459

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970886A NO316866B1 (no) 1994-09-02 1997-02-27 Funksjonelle terpyridin-metallkomplekser, fremgangsmater for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser, forbindelse for anvendelse i en terapeutisk fremgangsmate, farmasoytisk preparat og anvendelse av en forbindelse t

Country Status (15)

Country Link
US (1) US5925744A (no)
EP (1) EP0778844B1 (no)
JP (1) JPH10505354A (no)
AT (1) ATE229969T1 (no)
AU (1) AU695749B2 (no)
CA (1) CA2197788A1 (no)
CY (1) CY2435B1 (no)
DE (1) DE59510515D1 (no)
DK (1) DK0778844T3 (no)
ES (1) ES2191060T3 (no)
FI (1) FI970740A (no)
HU (1) HU217774B (no)
NO (1) NO316866B1 (no)
PT (1) PT778844E (no)
WO (1) WO1996007668A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739391B2 (en) * 1996-07-03 2001-10-11 President And Fellows Of Harvard College Oligonucleotide linker and techniques involving immobilized and linked oligonucleotides
US6376664B1 (en) * 1999-03-17 2002-04-23 The Ohio State University Cyclic bis-benzimidazole ligands and metal complexes thereof
US6407089B1 (en) 1999-12-23 2002-06-18 Trinapco Inc. Triazatrinaphthyrins and the use thereof
EP1244665B1 (en) * 1999-12-23 2005-08-10 Trinapco, Inc Triazatrinaphthyrins and the use thereof
GB0007764D0 (en) * 2000-03-30 2000-05-17 Bp Chem Int Ltd Polymerisation catalyst
FR2810406B1 (fr) * 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
WO2007125173A2 (en) 2006-05-03 2007-11-08 Baltic Technology Development, Ltd. Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
ES2668555T3 (es) 2008-05-27 2018-05-18 Dako Denmark A/S Composiciones y métodos para la detección de aberraciones cromosómicas con tampones de hibridación novedosos
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
US20110151457A1 (en) 2009-12-22 2011-06-23 Elitech Holding B.V. Hypertheromostable endonuclease iv substrate probe
EP2761028A1 (en) 2011-09-30 2014-08-06 Dako Denmark A/S Hybridization compositions and methods using formamide
EP2768974B1 (en) 2011-10-21 2017-07-19 Dako Denmark A/S Hybridization compositions and methods
CN114315702A (zh) * 2022-02-11 2022-04-12 南京邮电大学 一种基于低维镧系金属配合物X射线激发闪烁体Eu-TPC及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (en) * 1986-10-28 1990-09-19 The Johns Hopkins University Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids
DE68925278T2 (de) * 1988-02-26 1996-09-19 Worcester Found Ex Biology Hemmung von htlv-iii durch exogene oligonukleotide
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis
US5760191A (en) * 1993-02-05 1998-06-02 Nycomed Imaging As Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods

Also Published As

Publication number Publication date
DE59510515D1 (de) 2003-01-30
EP0778844A1 (de) 1997-06-18
FI970740A0 (fi) 1997-02-21
AU3474495A (en) 1996-03-27
NO316866B1 (no) 2004-06-07
JPH10505354A (ja) 1998-05-26
ATE229969T1 (de) 2003-01-15
FI970740A (fi) 1997-02-21
DK0778844T3 (da) 2003-03-31
ES2191060T3 (es) 2003-09-01
CA2197788A1 (en) 1996-03-14
NO970886L (no) 1997-04-25
PT778844E (pt) 2003-04-30
AU695749B2 (en) 1998-08-20
WO1996007668A1 (de) 1996-03-14
US5925744A (en) 1999-07-20
HU217774B (hu) 2000-04-28
EP0778844B1 (de) 2002-12-18
CY2435B1 (en) 2004-11-12
HUT77933A (hu) 1998-11-30

Similar Documents

Publication Publication Date Title
NO970886L (no) Funksjonelle terpyridin-metallkomplekser, fremgangsmåter for fremstilling derav og oligonukleotidkonjugater med terpyridin-metallkomplekser
DE69513395T2 (de) Zellulare abgabesystem mit cyclodextrin, für oligonukleotiden
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
WO1997026270A3 (en) Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
AU603525B2 (en) Tetrazole intermediates to antihypertensive compounds
HK1152246A1 (en) Compositions for treating cancer
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
DK0939765T3 (da) Glycokonjugater af modificerede camptothecin-derivater (A- eller B-ringbinding)
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
Ohnishi et al. Oxidative DNA Damage Induced by a Metabolite of 2–Naphthylamine, a Smoking‐related Bladder Carcinogen
AP2001002312A0 (en) New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments.
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
DE60041067D1 (de) Verfahren zur herstellung hochreiner nicht toxischer toxinfragmente
FR2795412B1 (fr) Nouveaux derives d'ammonium quaternaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX9709471A (es) Complejos metalicos multidentados y metodos para preparar y usar los mismos.
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
ES2014042A6 (es) Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo.
AP2000001835A0 (en) Agents.
ATE273027T1 (de) Zusammensetzung zur behandlung von entzündungen
MX9710501A (es) Metodo de purificacion por extraccion a partir de un medio liquido.
Oh Function and structure of ribonuclease P RNA complexed withtRNA
Sun et al. Effect of Nifedipine on Proliferation and DNA Synthesis of Human Gingival Fibroblasts
PL322847A1 (en) Condensed b-carbolins
UA32320A (uk) Спосіб лікування муковісцидозу
KR890002416A (ko) 물질 4181-2 및 그의 유도체의 제조방법

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees